Carmine Valenza, a member of the 2024-2025 PCE Outreach Team – Program in Clinical Effectiveness
Program in Clinical Effectiveness shared a post on LinkedIn:
“Meet Carmine Valenza, a member of the 2024-2025 PCE Outreach Team!
Carmine took the Program in Clinical Effectiveness in the summer of 2024, and is currently pursuing his MPH in Clinical Effectiveness at Harvard T.H. Chan School of Public Health. During his time in the Program, Carmine grew his passion for statistics and met many leaders in the field of breast cancer leading to his current role as an Affiliated Researcher at Dana-Farber Cancer Institute!
Interested in the career and academic growth the PCE fosters?
Apply now to the 2025 Program in Clinical Effectiveness (deadline 2/15/25)!”
Giuseppe Curigliano, Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology, reshared the post on LinkedIn, adding:
“Carmine Valenza a rising star on the global scenario.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023